Custom Search

Ketoconazole News

FDA Accepts Sebazole NDA

Barrier Therapeutics, Inc., a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New...

Displaying results 6 to 6 out of 6

< Previous



Use of this site is subject to the following terms of use